Telemedicine service Doctor on Demand raises $75M Series D led by General Atlantic, bringing the total raised to $240M
Leah Rosenbaum / Forbes :
Context & Ripple Effects
Doctor on Demand's $75M Series D is the largest disclosed round in this coverage window, landing at the peak of a pandemic-era funding surge — Medici raised $24M two months earlier explicitly citing COVID-19 demand, while Doctor Anywhere used its April Series B to push into Malaysia and the Philippines.
The lead investor is the through-line: General Atlantic previously anchored Doctolib's $170M round at a $1.1B valuation in 2019, so this is the firm's second major bet on appointment-and-visit platforms across two continents.
First-order effects
- Doctor on Demand gains $75M of runway at Series D scale — enough to outlast the smaller Series A/B players like Wheel and Curai still raising earlier rounds in the same window.
- General Atlantic now holds parallel positions in US (Doctor on Demand) and European (Doctolib) telemedicine, concentrating its healthcare-services thesis around virtual care.
Second-order effects
- Competitors face pressure to match the raise: Doctor Anywhere's follow-on Series C and Curai's Series B both landed within months, as late-stage money forces every regional player to fund expansion or cede ground.
- Supply-side intermediaries like Wheel — which staffs other telemedicine companies with clinicians — benefit as better-funded visit platforms scale patient volume and need external clinician capacity.
Third-order effects
- If the pattern holds, telemedicine consolidates into regionally dominant, institutionally backed platforms (US, Europe, Southeast Asia) rather than a long tail of startups, with Series D-scale capital becoming the entry ticket.
- COVID-era demand has converted telemedicine from an experimental channel into a funded category where investors distinguish infrastructure plays (Wheel, Curai) from consumer visit platforms (Doctor on Demand, Doctolib, Doctor Anywhere).
The trend: Telemedicine is moving from fragmented early-stage bets to regionally consolidated platforms backed by crossover-scale institutional capital, with General Atlantic among the firms building cross-market positions.